Candel Therapeutics, Inc. · NASDAQ:CADL
Tak Paul Peter sold 280,245 Candel Therapeutics, Inc. shares (Form 4)
Traded Sep 10 to Sep 11, 2026 · Filed Sep 11, 2026
From Sep 10 to Sep 11, 2026, Tak Paul Peter (Director, Chief Executive Officer) sold 280,245 Candel Therapeutics, Inc. shares at an average US$11.28 for US$3.16M under a trading plan, leaving 113,321 shares. Filed Sep 11, 2026 (Form 4).
- Sold
- 280,245 shares
- Price
- US$11.28 average (US$10.46 to US$11.50)
- Value
- US$3.16M
- Holding after
- 113,321 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Common Stock | Option exercise | 125,000 | US$1.55 | 393,566 | Direct |
| Sep 10, 2026 | Common Stock | Sale | 220,866 | US$11.50 | 172,700 | Direct |
| Sep 11, 2026 | Common Stock | Sale | 59,379 | US$10.46 | 113,321 | Direct |